Floatz logo

Bxcl501

Postoperative Delirium

Beijing Tiantan HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Postoperative Delirium cohort.

Asset / SponsorPhaseRating
PROPOFOL
RenJi Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Suvorexant
Mayo Clinic
Phase 4BB
Cyclopofol
RenJi Hospital
Phase 4BB

View all 23 →

Same molecule, other indications

Bxcl501 is also rated in:

Pain, ChronicDormant
A
Indicative ·
80 / 100
View asset →
Agitation,PsychomotorDormant
A
Indicative ·
80 / 100
View asset →
schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →